Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma

Immunotherapy has become a promising therapeutic option for Head and neck squamous cell carcinoma (HNSC). However, only a small percentage of patients could benefit from it, and the overall prognosis was far from satisfactory. In this study, by comprehensively computational analyses of hundreds of H...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiang, Weijie, Dai, Yifei, Xing, Xiaoyan, Sun, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921014/
https://www.ncbi.nlm.nih.gov/pubmed/33717423
http://dx.doi.org/10.1016/j.csbj.2021.01.046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921014/
https://www.ncbi.nlm.nih.gov/pubmed/33717423
http://dx.doi.org/10.1016/j.csbj.2021.01.046

Ejemplares similares